Status:
COMPLETED
Does Adding an Additional Numbing Medication Injection in the Thigh Help With Pain Control After Knee Replacement Surgery?
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
Knee Osteoarthritis
Knee Rheumatism
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
One common anesthetic that is performed for total knee replacement surgery is spinal anesthesia with an adductor canal regional block, which involves injecting numbing medication in the thigh region f...
Detailed Description
There is currently no consensus on the optimal strategy that provides the most effective postoperative analgesia while preserving ambulation and limiting side effects such as nausea and vomiting. The ...
Eligibility Criteria
Inclusion
- Patients scheduled to undergo total knee arthroplasty
- Planned use of regional anesthesia for procedure
- Willing and able to provide informed consent
Exclusion
- Patients on immunosuppressive therapy
- Patients with history of diabetes
- Patients with lower limb neuropathy
- Patients with history of chronic opioid use for \> 3 months, including but not limited to, fentanyl, morphine, oxycodone, methadone
- Patients with known allergy or intolerance to any drug used in the study
- Patients with history of alcohol or drug abuse
- Patients with history of intolerance of nonsteroidal anti-inflammatory drugs
- Patients with hepatic or renal insufficiency
- ASA score of 4 or greater
Key Trial Info
Start Date :
December 11 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 18 2018
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03326999
Start Date
December 11 2017
End Date
December 18 2018
Last Update
September 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029